Home  »  Companies   »  Can Altimmune Inc. (ALT) Remain Competitive?...

Can Altimmune Inc. (ALT) Remain Competitive?

Altimmune Inc. (NASDAQ:ALT) went up by 5.20% from its latest closing price compared to the recent 1-year high of $23.49. The company’s stock price has collected -7.23% of loss in the last five trading sessions.

Is It Worth Investing in Altimmune Inc. (NASDAQ :ALT) Right Now?

Plus, the 36-month beta value for ALT is at 0.25.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The average price from analysts is $29.14, which is $15.51 above the current price. ALT currently public float of 46.72M and currently shorts hold a 13.18% ratio of that float. Today, the average trading volume of ALT was 2.60M shares.

ALT’s Market Performance

ALT stocks went down by -7.23% for the week, with a monthly drop of -27.56% and a quarterly performance of 25.94%, while its annual performance rate touched -12.11%. The volatility ratio for the week stands at 9.13% while the volatility levels for the past 30 days are set at 11.87% for Altimmune Inc. The simple moving average for the period of the last 20 days is -26.60% for ALT stocks with a simple moving average of 42.76% for the last 200 days.

Analysts’ Opinion of ALT

Many brokerage firms have already submitted their reports for ALT stocks, with Jefferies repeating the rating for ALT by listing it as a “Buy.” The predicted price for ALT in the upcoming period, according to Jefferies is $30 based on the research report published on December 29th of the previous year 2021.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see ALT reach a price target of $35. The rating they have provided for ALT stocks is “Buy” according to the report published on June 02nd, 2021.

Guggenheim gave a rating of “Buy” to ALT, setting the target price at $36 in the report published on February 11th of the previous year.

ALT Trading at -13.51% from the 50-Day Moving Average

After a stumble in the market that brought ALT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.17% of loss for the given period.

Volatility was left at 11.87%, however, over the last 30 days, the volatility rate increased by 9.13%, as shares sank -30.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.90% upper at present.

During the last 5 trading sessions, ALT fell by -7.23%, which changed the moving average for the period of 200-days by +44.01% in comparison to the 20-day moving average, which settled at $17.89. In addition, Altimmune Inc. saw 45.74% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALT starting from Garg Vipin K, who sale 20,000 shares at the price of $20.02 back on Aug 31. After this action, Garg Vipin K now owns 236,797 shares of Altimmune Inc., valued at $400,322 using the latest closing price.

Garg Vipin K, the President and CEO of Altimmune Inc., sale 15,000 shares at $15.06 during a trade that took place back on Aug 12, which means that Garg Vipin K is holding 259,804 shares at $225,890 based on the most recent closing price.

Stock Fundamentals for ALT

Current profitability levels for the company are sitting at:

  • -1937.35 for the present operating margin
  • +87.50 for the gross margin

The net margin for Altimmune Inc. stands at -2201.43. Equity return is now at value -49.20, with -44.50 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 11.17.

Is The Trade Desk Inc. (TTD) a Keeper?

The Trade Desk Inc. (NASDAQ:TTD) went down by -2.60% from its latest closing price compared to the recent 1-year high of $114.09. The company’s stock